Correlation Between GlaxoSmithKline PLC and Rareview Capital
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Rareview Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Rareview Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Rareview Capital, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Rareview Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Rareview Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Rareview Capital.
Diversification Opportunities for GlaxoSmithKline PLC and Rareview Capital
0.94 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between GlaxoSmithKline and Rareview is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Rareview Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rareview Capital and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Rareview Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rareview Capital has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Rareview Capital go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Rareview Capital
If you would invest 2,041 in Rareview Capital on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Rareview Capital or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 4.55% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Rareview Capital
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Rareview Capital |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
GlaxoSmithKline PLC and Rareview Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Rareview Capital
The main advantage of trading using opposite GlaxoSmithKline PLC and Rareview Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Rareview Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rareview Capital will offset losses from the drop in Rareview Capital's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Rareview Capital vs. Dimensional ETF Trust | Rareview Capital vs. JPMorgan Inflation Managed | Rareview Capital vs. Goldman Sachs ETF | Rareview Capital vs. Dimensional ETF Trust |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |